This retrospective study demonstrates that the obesity paradox applies to patients receiving CAR T-cell therapy and that sarcopenia can exert long-lasting adverse effects on treatment responses. The data highlight use… Click to show full abstract
This retrospective study demonstrates that the obesity paradox applies to patients receiving CAR T-cell therapy and that sarcopenia can exert long-lasting adverse effects on treatment responses. The data highlight use of immuno-nutritional scores could aid in patient risk-stratification.
               
Click one of the above tabs to view related content.